ArticleThe Journal of general virology2022
History and classification of Aigai virus (formerly Crimean-Congo haemorrhagic fever virus genotype VI).
Open access · greenAbstract read
In one paragraph
Article in The Journal of general virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 41 citations in OpenAlex.
- Pathogenicity and virulence of Crimean-Congo hemorrhagic fever virus: From enzootic maintenance to severe human disease.Virulence · 2026Review
- Structural and mechanistic insights into protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus nucleocapsid protein.Nature communications · 2026Article
- Crimean-congo haemorrhagic fever virus in ticks and small ruminants in western Iran: epidemiological insights and genotyping.BMC infectious diseases · 2026Article
- Crimean-Congo hemorrhagic fever: An emerging threat in Europe.Virologica Sinica · 2026Review
- Widespread circulation of Crimean-Congo haemorrhagic fever virus in ticks, Corsica (France), 2024.One health (Amsterdam, Netherlands) · 2026Article
- CCHFV GP38 and GP85 interact with cell-surface glycosaminoglycans.Npj viruses · 2026Article
- Crimean-congo haemorrhagic fever virus circulates within broad ecological networks of ticks and vertebrates.PLoS neglected tropical diseases · 2026Article
- Article
- Review
- Detection and genetic characterization of Crimean-Congo hemorrhagic fever virus in ticks from western Spain (2017, 2020-2024).Frontiers in veterinary science · 2026Article
- Serological insights of Crimean-Congo haemorrhagic fever virus in podolic cattle bred in Italy.Frontiers in cellular and infection microbiology · 2026Article
- Co-circulation of Crimean-Congo hemorrhagic fever virus and spotted fever groupFrontiers in veterinary science · 2026Article
- Two autochthonous cases of Crimean-Congo haemorrhagic fever and the One Health response, Thessaly, Greece, 2025.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
- Genetic features of Orthonairovirus haemorrhagiae variants detected in ixodid ticks in Armenia.PLoS neglected tropical diseases · 2025Article
- Striking tick-borne virus diversity and potential reservoirs documented during One-Health-based cross-sectional screening in Anatolia.Parasites & vectors · 2025Article
- Article
- Molecular and Clinical Characterization of Crimean-Congo Hemorrhagic Fever in Bulgaria, 2015-2024.Pathogens (Basel, Switzerland) · 2025Article
- Review
- Re-emergence of Crimean Congo hemorrhagic fever virus in Kedougou, south-eastern Senegal in 2023: Epidemiological and zoological investigations of the first symptomatic human case.One health (Amsterdam, Netherlands) · 2025Article
- Serological evaluation of Crimean-Congo Hemorrhagic fever in humans with High-Risk professional exposure and in residual sera collected in 2022-2023 across Corsica (France).One health (Amsterdam, Netherlands) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 14 institutions in 10 countries.
Anna PapaNational Reference Centre for Arboviruses and Haemorrhagic Fever Viruses (Εθνικό Κέντρο Αναφοράς Αρμποϊών και Αιμορραγικών πυρετών, 1st Laboratory of Microbiology (Α' Εργαστήριο Μικροβιολογίας), School of Medicine (Τμήμα Ιατρικής), Aristotle University of Thessaloniki (Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης), Thessaloniki, Greece.
Marco MarklewitzInstitute of Virology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Sofia ParaskevopoulouInstitute of Virology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Aura R GarrisonThe members of the 2017-2020 International Committee on Taxonomy of Viruses (ICTV) Nairoviridae Study Group.
Sergey V AlkhovskyThe members of the 2017-2020 International Committee on Taxonomy of Viruses (ICTV) Nairoviridae Study Group.
Tatjana Avšič-ŽupancThe members of the 2017-2020 International Committee on Taxonomy of Viruses (ICTV) Nairoviridae Study Group.
Dennis A BenteThe members of the 2017-2020 International Committee on Taxonomy of Viruses (ICTV) Nairoviridae Study Group.
Éric BergeronThe members of the 2017-2020 International Committee on Taxonomy of Viruses (ICTV) Nairoviridae Study Group.
Felicity BurtDivision of Virology, National Health Laboratory Service and Division of Virology, University of the Free State, Bloemfontein, South Africa.
Nicholas Di PaolaThe members of the 2017-2020 International Committee on Taxonomy of Viruses (ICTV) Nairoviridae Study Group.
Koray ErgünayVirology Unit (Viroloji Birimi), Department of Medical Microbiology (Tıbbi Mikrobiyoloji Anabilim Dalı), Faulty of Medicine (Tıp Fakültesi), Hacettepe University (Hacettepe Üniversitesi), Ankara, Turkey.
Roger HewsonPublic Health England, Porton Down, Wiltshire, Salisbury, UK.
Ali MirazimiFolkhalsomyndigheten, Stockholm, Sweden.
Amadou Alpha SallInstitut Pasteur de Dakar, Dakar, Senegal.
Jessica R SpenglerThe members of the 2017-2020 International Committee on Taxonomy of Viruses (ICTV) Nairoviridae Study Group.
Thomas S PostlerDepartment of Microbiology & Immunology, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Gustavo PalaciosThe members of the 2017-2020 International Committee on Taxonomy of Viruses (ICTV) Nairoviridae Study Group.
Jens H KuhnIntegrated Research Facility at Fort Detrick. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, Maryland, USA.
United States Army Medical Research Institute of Infectious Diseases · USCenters for Disease Control and Prevention · USHumboldt-Universität zu Berlin · DEAristotle University of Thessaloniki · GRColumbia University · USD.I. Ivanovsky Institute of Virology Russian Academy of Medical Sciences · RUHacettepe University · TRInstitut Pasteur de Dakar · SNNational Health Laboratory Service · ZANational Institutes of Health · USPublic Health Agency of Sweden · SEPublic Health England · GBThe University of Texas Medical Branch at Galveston · USUniversity of Ljubljana · SI
Funding
Origin of the innate immunity suppression caused by nairovirus' protease activityR01AI151006 · NIAID · UNIVERSITY OF GEORGIA · PI PEGAN, SCOTT DUSAN · 2020 to 2024
$2.1MNIAID NIH HHS HHSN272201800013CNIAID NIH HHS R01 AI151006
Abstract
Crimean-Congo haemorrhagic fever virus (CCHFV) is the medically most important member of the rapidly expanding bunyaviral family
Indexed as
Hemorrhagic Fever, CrimeanHemorrhagic Fever Virus, Crimean-CongoGenotypeHumansAigai virusAIGVCrimean–Congo hemorrhagic feverNairoviridaeorthonairovirus
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.